Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

aisdevices.net

Stage

Seed | Dead

Total Raised

$1.29M

Last Raised

$50K

About AIS

Asclepius Innovative Solutions, or AIS, is a medical device company specializing in the development of medical devices.

AIS Headquarters Location

5909 Shelby Oaks Drive, Suite 234

Memphis, Tennessee, 38134,

United States

866-836-2778

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

AIS Patents

AIS has filed 5 patents.

The 3 most popular patent topics include:

  • Machining
  • Metal forming
  • Metalworking
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/7/2011

1/8/2013

Financial markets, Procurement, Contract law, Auctions, Pricing

Grant

Application Date

1/7/2011

Grant Date

1/8/2013

Title

Related Topics

Financial markets, Procurement, Contract law, Auctions, Pricing

Status

Grant

  • Where is AIS's headquarters?

    AIS's headquarters is located at 5909 Shelby Oaks Drive,, Memphis.

  • What is AIS's latest funding round?

    AIS's latest funding round is Seed.

  • How much did AIS raise?

    AIS raised a total of $1.29M.

  • Who are the investors of AIS?

    Investors of AIS include ZeroTo510 and Innova Memphis.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.